Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Elagolix did not effectively treat polycystic ovary syndrome.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Ritlecitinib can help about 14,000 people with severe hair loss.

Apremilast did not work for treating severe alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.